This message contains images. If you don't see images, click here to view.
Advertise in this news brief.



Text Version   RSS   Subscribe   Unsubscribe   Archive   Media Kit |  Histology Marketplace:     

Home   History   Meeting Calendar   Career Center   Certification   Contact Us    



 




NSH NEWS

Happy Thanksgiving from NSH
NSH
The National Society for Histotechnology would like to thank all members of the society; we appreciate your support each year, and we hope to continue to be your main source for histology education and resources. Thank you for all of your hard work and dedication in the field of histology. We hope you have a wonderful holiday with your family and friends.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  




Cardinal Health offers $20,000 scholarship with urEssential Award
NSH
The urEssential Award offered by Cardinal Health is a way to recognize the unsung heroes in our laboratories. The laboratory personnel who are working behind the scenes that help people live longer, healthier lives. In 2014, NSH Credentials Chair, Debra Wood was named the recipient of the award and could not be more happier for her institution. She stated "We are now able to offer one of our students each year a $1,000 scholarship. It made my dream come true!" Share your story by Feb. 28, it could be worth a $20,000 scholarship to students seeking careers in laboratory science. Learn more.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


SPONSORED CONTENT


TOP STORIES


Whistleblower lawsuits at US clinical pathology laboratories are rising
Dark Daily
Whistleblower activity across the medical laboratory industry seems to be increasing. This can be both a positive and a negative trend for pathologists and clinical laboratory managers. On the positive side, a whistleblower lawsuit that is joined by the U.S. Department of Justice and state attorney generals is one way to curb the illegal marketing and business practices of those medical lab companies willing to gain a competitive market advantage by pushing their interpretation of federal and state laws beyond legal limits.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  GBI Cost Effective Products

GBI Labs produces the largest selection of secondary detection kits, from single to multiple detection kits, with wide range host species. We provide FREE samples to 1st time users. Staining with our kits results in similar or better sensitivity than other detection kits on the market with 20%-30% cost less.
 


US proposal would greatly expand transparency of clinical trials
Forbes
The U.S. Department of Health and Human Services recently proposed new rules that would greatly expand the number of clinical trials that companies and researchers are required to report. "Medical advances would not be possible without participants in clinical trials," said NIH Director Francis Collins. "We owe it to every participant and the public at large to support the maximal use of this knowledge for the greatest benefit to human health. This important commitment from researchers to research participants must always be upheld."
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


New insight can help determine when mouse models are good stand-ins for studying humans
Medical Xpress
For decades, the mouse has been a mainstay for researchers studying human diseases because the two species share many of the same genes. But now, a comprehensive analysis of the inner workings of the DNA in humans and mice has uncovered some striking differences in the way their genes are controlled. While the research also shows many similarities in gene regulation in humans and mice, the differences provide new information to help scientists determine when the mouse is a good stand-in to study human biology and disease and when it may have limitations.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




Medicare price cuts may slow total overall hospital spending growth
Dark Daily
Contrary to the predictions of some analysts, a recent study suggests that slowing Medicare price growth by lowering hospital reimbursements will slow hospital utilization and spending for all age groups. For pathologists and clinical laboratory managers, the study represents credible evidence that cuts in Medicare prices cause a measurable and linked decrease in hospital utilization for both the elderly and the non-elderly.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


IN THE NEWS


New mouse model better represents JC virus that infects MS patients
MS News Today
Researchers in the laboratory of Steve Goldman, M.D., Ph.D., co-director of University of Rochester Center for Translational Neuromedicine, are delving deeper into the science behind progressive multifocal leukoencephalopathy, a disease caused by the JC virus, which commonly affects multiple sclerosis patients and others with compromised immune systems. The team aims to improve the ways by which scientists study PML and test for new treatments.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Tumor screening: Making resistance futile?
PHG Foundation
Cancer treatments are at the front line of personalized approaches to healthcare, with genetic testing and analysis of tumors allowing the use of the most effective drugs to attack them, including new biologically targeted treatments that can be highly effective without the side-effects (toxicity) of wider-acting drugs. However, as with infectious pathogens, tumors can become resistant to even the most powerful prescribed treatment, often within a few months, rendering the patient's original course of therapy futile.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Measuring complexity: The intelligent clinical trial
Forbes
For a new drug to be deemed effective and safe — both in the eyes of researchers and FDA — a drug must go through rigorous clinical trials. It is a complex, lengthy and expensive process needed to ensure therapeutic efficacy and safety of any new drug. Depending on a trial's design, complexity — measured in terms of number of activities and people involved — can vary greatly.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Vitamin B3 actually cures a liver cancer in mice
Cherry Creek News
The power of B vitamins continue to impress as research into these essential micronutrients continues. The first mouse model that faithfully reproduces the steps of human HCC development has been developed by researchers. The results of the study indicate that diets rich in nicotinamide riboside, a derivative of vitamin B3, protect these mice from developing HCC in its most initial stage, when genotoxic stress is damaging cellular DNA. They also show a curative effect of the diet in those mice that had previously developed the disease.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Nail stem cells are highly versatile
Laboratory Equipment
VideoBrief There are plenty of body parts that don't grow back when you lose them. Nails are an exception, and a new study in PNAS reveals some of the reasons why. A team of USC Stem Cell researchers led by principal investigator Krzysztof Kobielak and co-first authors Yvonne Leung and Eve Kandyba has identified a new population of nail stem cells, which have the ability to either self-renew or undergo specialization or differentiation into multiple tissues.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    NSH webinar: What Happened to My IHC and What Caused It? Nov. 26 (NSH)
Scientists uncover vast numbers of DNA 'blind spots' that may hide cancer-causing mistakes (Cancer Research UK)
New hope for halting cell death caused by disease (Medical Xpress)
Texas section of the American Association of Clinical Chemistry hosts all-star lineup of clinical lab experts to share successes at improving lab test utilization (Dark Daily)

Don't be left behind. Click here to see what else you missed.


 

Under the Microscope
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Ashley Whipple, Senior Content Editor, 469.420.2642   
Contribute news

This edition of Under the Microscope was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
Nov 25, 2014 Blast
Nov. 19, 2014
Nov. 18, 2014 Blast
Nov. 12, 2014



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063